Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleExperimental Studies

Molecular Diagnosis of MACC1 Status in Lung Adenocarcinoma by Immunohistochemical Analysis

GU CHUNDONG, HIDETAKA URAMOTO, TAKAMITSU ONITSUKA, HIDEHIKO SHIMOKAWA, TAKASHI IWANAMI, MAKOTO NAKAGAWA, TSUNEHIRO OYAMA and FUMIHIRO TANAKA
Anticancer Research April 2011, 31 (4) 1141-1145;
GU CHUNDONG
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIDETAKA URAMOTO
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: hidetaka{at}med.uoeh-u.ac.jp
TAKAMITSU ONITSUKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
HIDEHIKO SHIMOKAWA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TAKASHI IWANAMI
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MAKOTO NAKAGAWA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
TSUNEHIRO OYAMA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
FUMIHIRO TANAKA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Figures & Data

Figures

  • Tables
  • Figure 1.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1.

    Representative IHC staining. A: Positive staining for MACC1 with brown stained cytoplasm is shown at low power (original magnification ×40), the IS and PS were judged to be 3 and 3, respectively, in this sample. Therefore, the IHC of this tumor was assumed to be positive, with a score of 6. B: Representative IHC staining of tumors at high power (original magnification ×400). C: Negative staining for MACC1 is shown at low power. D: Negative staining for MACC1 is shown at high power.

  • Figure 2.
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2.

    Kaplan-Meier DFS curves stratified by MACC1 expression. The heavy and narrow lines show the positive and negative expression of the MACC1, respectively.

Tables

  • Figures
  • Table I.
  • Table II.
  • Table III.
  • Table IV.
  • Table V.
  • Table VI.
PreviousNext
Back to top

In this issue

Anticancer Research
Vol. 31, Issue 4
April 2011
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Molecular Diagnosis of MACC1 Status in Lung Adenocarcinoma by Immunohistochemical Analysis
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
2 + 11 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Molecular Diagnosis of MACC1 Status in Lung Adenocarcinoma by Immunohistochemical Analysis
GU CHUNDONG, HIDETAKA URAMOTO, TAKAMITSU ONITSUKA, HIDEHIKO SHIMOKAWA, TAKASHI IWANAMI, MAKOTO NAKAGAWA, TSUNEHIRO OYAMA, FUMIHIRO TANAKA
Anticancer Research Apr 2011, 31 (4) 1141-1145;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Molecular Diagnosis of MACC1 Status in Lung Adenocarcinoma by Immunohistochemical Analysis
GU CHUNDONG, HIDETAKA URAMOTO, TAKAMITSU ONITSUKA, HIDEHIKO SHIMOKAWA, TAKASHI IWANAMI, MAKOTO NAKAGAWA, TSUNEHIRO OYAMA, FUMIHIRO TANAKA
Anticancer Research Apr 2011, 31 (4) 1141-1145;
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Patients and Methods
    • Results
    • Discussion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • MACC1 Induces Tumor Progression in Transgenic Mice and Colorectal Cancer Patients via Increased Pluripotency Markers Nanog and Oct4
  • Prediction of Recurrence after Complete Resection in Patients with NSCLC
  • The EMT Status in the Primary Tumor Does Not Predict Postoperative Recurrence or Disease-free Survival in Lung Adenocarcinoma
  • Google Scholar

More in this TOC Section

  • Ibrutinib Inhibits Tumor Progression, Alleviates Pain, and Protects the Tibia in a Bone Metastasis Model of Lung Cancer
  • Co-expression of PD1/PD-L1 on Tumor Cells Is Involved in the Regulation of Cell Proliferation
  • Down-regulation of ACSM3 Promotes Tumorigenesis in Breast Cancer
Show more Experimental Studies

Similar Articles

Anticancer Research

© 2025 Anticancer Research

Powered by HighWire